Argenta becomes NOAH member
Argenta prides itself on a 'Molecule to Market' approach, partnering across the whole development cycle of a product.
The National Office of Animal Health (NOAH) has announced that Argenta, global contract research organisation (CRO) and contract development and manufacturing organisation (CDMO) has become an Associate member.
Argenta, who specialises in animal health, partners with customers to develop technologies and products. The company works in pharmaceutical sciences, independent research, clinical studies and solutions, regulatory services and manufacturing.
Dawn Howard, chief executive at NOAH, welcomed the new member: “We are delighted to welcome Argenta to NOAH.
“Their role as a specialist research and manufacturing organisation highlights how our sector contributes to the UK science base, and we look forward to working with them, helping make NOAH a stronger voice for our industry on the many challenges and opportunities we face at this time.”
Marketing specialist at Argenta, Dr Ian Williams, added: “We have joined NOAH to keep up-to-date with relevant animal health news, policy and regulatory changes.
“We are also looking forward to the networking opportunities for Argenta with other NOAH members, that membership will bring.”
The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.
